Male Contraception.


Journal

Seminars in reproductive medicine
ISSN: 1526-4564
Titre abrégé: Semin Reprod Med
Pays: United States
ID NLM: 100909394

Informations de publication

Date de publication:
Nov 2023
Historique:
pubmed: 20 12 2023
medline: 20 12 2023
entrez: 19 12 2023
Statut: ppublish

Résumé

Approximately 40 to 50% of pregnancies are unintended. Contraceptive use significantly reduces the risk of unintended pregnancy. Approximately 70% of couples' contraceptive use is female and 30% is male, attributable to the reliance on condoms and vasectomies. Unfortunately, many women cannot use currently available contraceptives due to medical contraindications or side effects. At the same time, men want additional safe and effective contraceptive methods. Because of this, work to develop novel, safe, and effective male contraceptives is underway. This review will briefly discuss the pros and cons of condoms and vasectomies, and then describe research into the development of novel methods of male contraception, by the mechanism of action of the contraceptive. First, we will discuss male contraceptives that block sperm transmission. Next, we will discuss male contraceptives that impair sperm production. Lastly, we will discuss male contraceptives that impair sperm function.

Identifiants

pubmed: 38113922
doi: 10.1055/s-0043-1777757
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

279-286

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

John K Amory (JK)

Department of Medicine, The Center for Research in Reproduction and Contraception, University of Washington, Seattle, Washington.

Classifications MeSH